mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.3 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
pitstop2 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.3 |